14/02/2024 - Covid-19
It is a monoclonal antibody with prophylactic and therapeutic action, isolated from blood samples of a patient infected by SARS-CoV-2 during the first wave of the pandemic. The antibody has been designed and developed by researchers from the Hospital del Mar Research Institute, the IrsiCaixa AIDS Research Institute, the National Center for Biotechnology and the Center for Genomic Regulation. In addition, this new treatment has been patented pending commercial development. This new treatment has been patented pending commercial development. The results of the work have been published in the journal Nature Communications.
Més informació "New antibody blocks all SARS-CoV-2 variants in preclinical models"
09/02/2024 - Press release
An international study has used a computational biology tool that, by analysing a multitude of biological data from multiple sclerosis patients ranging from genetic information to the whole organism, reveals the relationship between elements of different biological scales and improves our knowledge and the diagnosis of the disease. International research led by the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University, in collaboration with Hospital del Mar, Hospital Clínic, Charité - Medical University of Berlin, and the universities of Oslo and Genoa, has developed a computational biology tool, based on multi-level network analysis, to achieve an integrated vision of multiple sclerosis. This tool could be used to study other complex diseases such as types of dementia.
07/02/2024 - Institutional news
The Carlos III Health Institute has approved the renewal of this accreditation, first achieved in 2013. On January 30, the Carlos III Health Institute approved the renewal of the Hospital del Mar Research Institute's accreditation as a Health Research Institute. The center thus passes, for the second time, the audit required to maintain this accreditation, which it received for the first time in 2013.
06/02/2024 - General information
Sociodemographic, epidemiological, technological and societal demand changes make it necessary to face a transformation of the health system in order to promote both its own sustainability and the improvement of expected health outcomes. In order to carry out this transformation, long term strategies are needed, which go beyond the cycles of government, as well as the commitment between the different agents that have influence there. For this reason, it is considered necessary to do so through a National Health Pact.
Més informació "Citizen Participation Process in the National Health Pact"
02/02/2024 - Institutional news
The laboratory director, Dr. Rosa Ventura Alemany, has been invited to join different expert committees of the agency starting this year. Dr. Ventura will be a member of the expert committee of anti-doping laboratories, which has the function of managing and monitoring the accreditation of laboratories and updating the regulations of the World Anti-Doping Agency (WADA). In addition, she will also be a member of the working group on the use of dried blood spots (DBS) in doping controls and of the MRPL (minimum required performance levels) working group, which defines the detection limits that laboratories have to achieve for the different substances prohibited in sport in order to perform effective doping controls.
30/01/2024 - Press release
This is revealed by the largest observational study in this field carried out to date in the world. It is published in the journal Nutrients. The work is based on data from the UK Biobank database and has made it possible to analyze information from more than 260,000 people. Its conclusions may allow a more detailed definition of future studies on omega-3 supplementation for the prevention of dementia. The potential benefits of these fatty acids are maximal in men over 60 and in dementias other than Alzheimer's disease.
26/01/2024 - General information
Drs. Anna Bigas and David Sprinzak from Tel Aviv University have published comprehensive reviews as editors on the mechanisms of cell communication in various tissues. This review is a potential study to understand how life and diseases develop.
Més informació "Local Cellular Interactions Analyzed in Current Opinion in Cell Biology"
19/01/2024 - General information
The Minister of Health officially announced the cardiologist's appointment from Hospital del Mar and researcher at the Hospital del Mar Research Institute last December. Dr. Tizón replaces Dr. Josepa Mauri from Hospital Germans Trias i Pujol, who held this position for the past 8 years.
10/01/2024 - Press release
Functional alterations in the brains of individuals with this condition coincide with the distribution of these neurons in the same brain. These neurons are responsible for filtering external information reaching the brain. Their functioning is altered in individuals with schizophrenia, which explains the majority of their symptoms. This discovery is the first time that this alteration can be identified as a possible origin of schizophrenic symptoms, and it opens the door to seeking new targeted treatments with fewer patient side effects.
28/12/2023 - Press release
An observational study conducted by researchers from Pompeu Fabra University and Hospital del Mar determines that the intradermal administration of the JYNNEOS vaccine against smallpox induces an efficient immune response that should protect people living with HIV from contracting the monkeypox virus.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
